KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS)

$0 None (None%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 63

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) News Sources

Viridian Therapeutics Announces Collaboration and License Agreement with Kissei Pharmaceutical to Develop and Commercialize Veligrotug and VRDN-003 in Japan with an Upfront Payment of $70 Million and up to $315 Million in Milestone Payments

30-07-2025

yahoo.com

Viridian and Kissei to advance veligrotug and VRDN-003 in Japan

31-07-2025

pharmaceutical-technology.com

Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update

05-08-2025

yahoo.com

Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results

06-08-2025

yahoo.com

Viridian Therapeutics, Kissei Pharmaceutical Partner for Japanese Development of Thyroid Eye Disease Therapies, Securing $70M Upfront

18-08-2025

yahoo.com

Is Now the Right Moment for Kissei Pharmaceutical After Its 2025 Earnings Jump?

15-09-2025

yahoo.com

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment

07-10-2025

yahoo.com

Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Treatment Options | DelveInsight

12-03-2026

yahoo.com

Amgen Japanese Partner Urges Caution On Tavneos Use

18-05-2026

yahoo.com

Update: Amgen Kidney Disease Drug Under Scrutiny in Japan

18-05-2026

yahoo.com

KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) Sentiment Trend

0 25 50 75 100 84 71 80 76 87 88 59 76 5 5 30-07-2025 31-07-2025 05-08-2025 06-08-2025 18-08-2025 15-09-2025 07-10-2025 12-03-2026 18-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) FAQs

toggle

What is the current price of KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS)?

The current price of KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) is $0.


toggle

KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) since the previous trading day is $None.


toggle

KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) since the previous trading day is None%.


toggle

What is the most recent average sentiment score for KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS)?

The most recent average sentiment score for KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) is 63 out of 100.


toggle

What is the most recent average sentiment for KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS)?

The most recent sentiment for KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS) is .


SEC-8K** Filing Available For KISSEI PHARMACEUTICAL CO LTD (KSPHF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.